{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:30Z","timestamp":1789913670678,"version":"4.0.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004178","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T18:21:27Z","timestamp":1445365287000},"page":"e0004178","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy"],"prefix":"10.1371","volume":"9","author":[{"given":"Ines","family":"Lakhal-Naouar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie M.","family":"Slike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi E.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Marovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"TR Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"FP Heinzel","year":"1989","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.micpath.2013.02.004","article-title":"Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals","volume":"57","author":"Souza M de Assis","year":"2013","journal-title":"Microb Pathog"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"P Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","article-title":"Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production","volume":"70","author":"LR Castellano","year":"2009","journal-title":"Hum Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"PA Darrah","year":"2007","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2011.04536.x","article-title":"Multifunctional CD4(+) T cells in patients with American cutaneous leishmaniasis","volume":"167","author":"AB Macedo","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2012.00080","article-title":"T helper1\/t helper2 cells and resistance\/susceptibility to leishmania infection: is this paradigm still relevant?","volume":"3","author":"J Alexander","year":"2012","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"P Minodier","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1586\/14787210.2014.916614","article-title":"Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?","volume":"12","author":"M Vanaerschot","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1517\/14656566.8.16.2689","article-title":"Cutaneous leishmaniasis: therapeutic strategies and future directions","volume":"8","author":"M Ameen","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: clinical syndromes and treatment","volume":"107","author":"BS McGwire","year":"2014","journal-title":"QJM"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"TR Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4269\/ajtmh.1997.57.309","article-title":"Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico","volume":"57","author":"O Velasco-Castrejon","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12205","article-title":"Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India","volume":"168","author":"RA Bumb","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7205\/MILMED-D-11-00161","article-title":"Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial","volume":"177","author":"N Safi","year":"2012","journal-title":"Mil Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1745-6215-13-58","article-title":"Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis","volume":"13","author":"L Lopez","year":"2012","journal-title":"Trials"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2230.2007.02405.x","article-title":"Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate","volume":"32","author":"G Sadeghian","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial","volume":"40","author":"R Reithinger","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1371\/journal.pntd.0000628","article-title":"A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection","volume":"4","author":"NE Aronson","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/344302","article-title":"Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells","volume":"186","author":"MA Marovich","year":"2002","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e70164","DOI":"10.1371\/journal.pone.0070164","article-title":"HIV DNA reservoir increases risk for cognitive disorders in cART-naive patients","volume":"8","author":"VG Valcour","year":"2013","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e13983","DOI":"10.1371\/journal.pone.0013983","article-title":"Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate","volume":"5","author":"JR Currier","year":"2010","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e24254","DOI":"10.1371\/journal.pone.0024254","article-title":"A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells","volume":"6","author":"MA Eller","year":"2011","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","article-title":"CD8(+) T cells in leishmania infections: friends or foes?","volume":"3","author":"S Stager","year":"2012","journal-title":"Front Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2133.2005.06647.x","article-title":"Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions","volume":"153","author":"AM Da-Cruz","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0100-879X1998000100019","article-title":"Immunologic patterns associated with cure in human American cutaneous leishmaniasis","volume":"31","author":"SG Coutinho","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"TA Fehniger","year":"2003","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jcla.20291","article-title":"Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment","volume":"23","author":"LC Reis","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/eji.200940278","article-title":"NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d","volume":"41","author":"C Kuylenstierna","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"863625","DOI":"10.1155\/2014\/863625","article-title":"The function of CD3+CD56+ NKT-like cells in HIV-infected individuals","volume":"2014","author":"Y Jiang","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cellimm.2012.11.006","article-title":"Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure","volume":"279","author":"MC Brelaz-de-Castro","year":"2012","journal-title":"Cell Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12879-015-0799-x","article-title":"Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy","volume":"15","author":"R Ferraz","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref35","first-page":"251","article-title":"T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy","volume":"9","author":"AM Da-Cruz","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1128\/IAI.62.6.2614-2618.1994","article-title":"Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis","volume":"62","author":"AM Da-Cruz","year":"1994","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/expr.1996.0100","article-title":"T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure","volume":"84","author":"SG Coutinho","year":"1996","journal-title":"Exp Parasitol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0074-02762001000100010","article-title":"Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment","volume":"96","author":"VP Toledo","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.intimp.2008.03.016","article-title":"Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology","volume":"8","author":"KJ Gollob","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/IAI.69.5.3232-3239.2001","article-title":"Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis","volume":"69","author":"RL Bottrel","year":"2001","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1004396","DOI":"10.1371\/journal.ppat.1004396","article-title":"MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania major","volume":"10","author":"Z Mou","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/icb.2014.99","article-title":"Double negative (DN) alphabeta T cells: misperception and overdue recognition","volume":"93","author":"MN Martina","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1995.53.273","article-title":"Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis","volume":"53","author":"EM Carvalho","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.0141-9838.2004.00668.x","article-title":"Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells","volume":"25","author":"S Herath","year":"2003","journal-title":"Parasite Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<237::AID-IMMU237>3.0.CO;2-O","article-title":"The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity","volume":"28","author":"F Conceicao-Silva","year":"1998","journal-title":"Eur J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/jid.2013.4","article-title":"CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNgamma(+)-mediated parasite killing in human cutaneous leishmaniasis","volume":"133","author":"Cda S Santos","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1128\/IAI.69.12.7453-7460.2001","article-title":"Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers","volume":"69","author":"MM Pompeu","year":"2001","journal-title":"Infect Immun"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-3083.2012.02717.x","article-title":"American tegumentary leishmaniasis: cytokines and nitric oxide in active disease and after clinical cure, with or without chemotherapy","volume":"76","author":"MA Souza","year":"2012","journal-title":"Scand J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.trstmh.2005.08.011","article-title":"Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy","volume":"100","author":"IM Lobo","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/cei.12364","article-title":"Antigen-triggered interferon-gamma and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease","volume":"177","author":"RS Nogueira","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/1471-2334-13-529","article-title":"Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis","volume":"13","author":"AM Carvalho","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/502980","article-title":"CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells","volume":"193","author":"AP Campanelli","year":"2006","journal-title":"J Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14712598.3.6.875","article-title":"The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection","volume":"3","author":"Y Belkaid","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10875-008-9248-6","article-title":"Role of endogenous and induced regulatory T cells during infections","volume":"28","author":"E Wohlfert","year":"2008","journal-title":"J Clin Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e1627","DOI":"10.1371\/journal.pntd.0001627","article-title":"Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species","volume":"6","author":"D Rodriguez-Pinto","year":"2012","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T14:38:25Z","timestamp":1692110305000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004178"}},"subtitle":[],"editor":[{"given":"Abhay R","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004178","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}